FPS-ZM1对糖基化终产物诱导海马区Aβ代谢水平的影响

doi:10.6040/j.issn.1671-7554.0.2013.688

山东大学学报（医学版） ›› 2014, Vol. 52 ›› Issue (7): 1-6.doi: 10.6040/j.issn.1671-7554.0.2013.688

• 基础医学 • 下一篇

FPS-ZM1对糖基化终产物诱导海马区Aβ代谢水平的影响

孙梦晗, 洪艳, 侯训尧, 马莹娟, 申超, 殷青青, 陈健, 罗鼎真, 刘雪平

山东大学附属省立医院老年神经科, 山东济南 250021

收稿日期:2013-11-15 修回日期:2014-06-12 出版日期:2014-07-10 发布日期:2014-07-10
通讯作者: 刘雪平。E-mail：lxp6203@163.com E-mail:lxp6203@163.com
基金资助:
国家自然科学基金（30971036）；山东省自然科学基金（Y2008C13）

Effects of FPS-ZM1 on the metabolism of Aβ induced by advanced glycation end products in hippocampus

SUN Menghan, HONG Yan, HOU Xunyao, MA Yingjuan, SHEN Chao, YIN Qingqing, CHEN Jian, LUO Dingzhen, LIU Xueping

Department of Senile Neurology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China

Received:2013-11-15 Revised:2014-06-12 Online:2014-07-10 Published:2014-07-10

摘要/Abstract

摘要： 目的观察RAGE受体阻断剂FPS-ZM1对高级糖基化终产物（AGEs）诱导海马区Aβ及相关代谢因素表达水平的影响。方法将40只大鼠随机分为生理盐水组（NC组）、FPS-ZM1对照组、AGEs组和FPS-ZM1组。向大鼠海马区注射AGEs，以建立AGEs脑损伤模型，并用FPS-ZM1干预。造模3周后HE染色观察海马区神经元病理改变；Morris水迷宫实验检测逃逸潜伏期（EL）；蛋白印迹法检测各组RAGE、p-NF-κB、BACE1和APP的蛋白表达；酶联免疫吸附法检测各组Aβ_1-40、 Aβ_1-42的水平。结果与NC组、FPS-ZM1对照组相比， AGEs组及FPS-ZM1组海马神经元排列疏松，p-NF-κB、BACE1和APP的蛋白表达和Aβ_1-40、Aβ_1-42浓度均升高（P<0.01）；但FPS-ZM1组上述改变均明显低于AGEs组，同时AGEs组 RAGE表达明显增强，EL显著延长（P<0.01），但FPS-ZM1组与NC组和FPS-ZM1对照组相比无统计学差异（P>0.05）。结论 RAGE受体阻断剂FPS-ZM1能通过降低Aβ及相关代谢因素的表达水平，有效抑制AGEs所致的脑损伤。

关键词: Aβ, 高级糖基化终末产物, β分泌酶, 阿尔兹海默病, RAGE受体阻断剂

Abstract: Objective To detect the effects of RAGE inhibitor FPS-ZM1 on the metabolism of Aβ and related factors induced by advanced glycation end products (AGEs) in hippocampus. Methods A total of 40 Wistar rats were randomly divided into normal control group (NC group), FPS-ZM1 control group, AGEs group and FPS-ZM1 group. AGEs were injected into hippocampus to produce brain injury models of AGEs and the rats were intervened by FPS-ZM1. After the animal models were constructed for 3 weeks, HE staining was used to detect the pathological change. The escape latency (EL) was assayed with Morris water maze test. Western blotting was performed to detect the expression of RAGE, p-NF-κB, BACE1 and APP protein expression. The levels of Aβ_1-40 and Aβ_1-42 of each group were measured by enzyme linked immunosorbent assay. Results Compared with NC group and FPS-ZM1 control group, the neurons in hippocampus of AGEs group and FPS-ZM1 group arranged more irregularly, and the protein expressions of p-NF-κB, BACE1 and APP, and the concentrations of Aβ_1-40 and Aβ_1-42 were obviously increased (P<0.01), but each index of FPS-ZM1 group was evidently lower than that of the AGEs group. Meanwhile, in the AGEs group, theprotein expression of RAGE was significantly higher and the EL was also longer (P<0.01), but the above indexes in FPS-ZM1 group were not significantly different (P>0.05). Conclusion The RAGE inhibitor FPS-ZM1 can reduce the metabolism of Aβ and related factors to effectively suppress the AGEs brain injury.

Key words: Advanced glycation end products, RAGE inhibitor, Aβ, Alzheimer’s disease, β-secretase

中图分类号:

R749.1

孙梦晗, 洪艳, 侯训尧, 马莹娟, 申超, 殷青青, 陈健, 罗鼎真, 刘雪平. FPS-ZM1对糖基化终产物诱导海马区Aβ代谢水平的影响[J]. 山东大学学报（医学版）, 2014, 52(7): 1-6.

SUN Menghan, HONG Yan, HOU Xunyao, MA Yingjuan, SHEN Chao, YIN Qingqing, CHEN Jian, LUO Dingzhen, LIU Xueping. Effects of FPS-ZM1 on the metabolism of Aβ induced by advanced glycation end products in hippocampus[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(7): 1-6.

参考文献

[1] Takeuchi M, Yamagishi S. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease [J]. Curr Pharm Des, 2008, 14(10):973-978.
[2] Castellani R J, Harris P L, Sayre L M, et al. Active glycation in neurofibrillary pathology of Alzheimer disease:N(epsilon)-(carboxymethyl) lysine and hexitol-lysine [J]. Free Radic Biol Med, 2001, 31(2):175-180.
[3] Srikanth V, Maczurek A, Phan T, et al. Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease [J]. Neurobiol Aging, 2011, 32(5):763-777.
[4] Wang X Y, Tang S S, Hu M, et al. Leukotriene D4 induces amyloid-β generation via CysLT(1) R-mediated NF-κB pathways in primary neurons [J]. Neurochem Int, 2013, 62(3):340-347.
[5] Deane R, Singh I, Sagare A P, et al. A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease [J]. J Clin Invest, 2012, 122(4):1377-1392.
[6] Lue L F, Walker D G, Brachova L, et al. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease:identification of a cellular activation mechanism[J]. Exp Neurol, 2001, 171(1):29-45.
[7] Deane R, Du Yan S, Submamaryan R K, et al. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain [J]. Nat Med, 2003, 9(7):907-913.
[8] Miguel-Hidalgo J J, Cacabelos R. Beta- amyloid (1-40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield [J]. Acta Neuropathol,1998, 95(5):455-465.
[9] Vlassara H, Bucala R, Striker L, et al. Pathogenic effects of advanced glycosylation:Biologic and clinical implication for diabetes and ageing [J]. Lab Invest, 1994, 70(2):138-151.
[10] Li L, Hlscher C. Common pathological processes in Alzheimer disease and type 2 diabetes:a review [J]. Brain Res Rev, 2007, 56(2):384-402.
[11] Colaco C A, Ledesma M D, Harrington C R, et al. The role of the Maillard reaction in other pathologies:Alzheimer's disease [J]. Nephrol Dial Transplant,1996, Suppl 5:7-12.
[12] Belles M, Gomez M, Domingo J L, et al. Effects of simultaneous administration of desferrioxamine and tacrine in rats [J]. Vet Hum Toxicol, 1998, 40(5):269-272.
[13] Takeuchi M, Yamagishi S. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease [J]. Curr Pharm Des, 2008, 14(10):973-978.
[14] Guglielmotto M, Aragno M, Tamagno E, et al. AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activation [J]. Neurobiol Aging, 2012, 33(1):196. e13-196.e27.
[15] Xie J, Méndez J D, Méndez-Valenzuela V, et al. Cellular signalling of the receptor for advanced glycation end products (RAGE)[J]. Cell Signal, 2013, 25(11):2185-2197.
[16] Rossner S, Sastre M, Bourne K, et al. Transcriptional and translational regulation of BACE1 expression-implications for Alzheimer's disease [J]. Prog Neurobiol, 2006, 79(2):95-111.
[17] Zlokovic B V. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders [J]. Nat Rev Neurosci， 2011, 12(12):723-738.
[18] Yan S D, Chen X, Fu J, et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease [J]. Nature， 1996, 382(6593):685-691.
[19] Arancio O, Zhang H P, Chen X, et al. RAGE potentiates Aβinduced perturbation of neuronal function in transgenic mice [J]. EMBO J, 2004, 23(20):4096-4105.
[20] Blatnik M, Frizzell N, Thorpe S R, et al. Inactivation of glyceraldehyde -3 -phosphate dehydrogenase by fumarate in diabetes:formation of S-(2 -succinyl ) cysteine,a novel chemical modification of protein and possible biomarker of mitochondrial stress [J]. Diabetes, 2008, 57(1):41-49.
[21] Sabbagh M N, Agro A, Bell J, et al. PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease [J]. Alzheimer Dis Assoc Disord, 2011, 25(3):206-212.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed

FPS-ZM1对糖基化终产物诱导海马区Aβ代谢水平的影响

Effects of FPS-ZM1 on the metabolism of Aβ induced by advanced glycation end products in hippocampus

PDF (PC)

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 4

多维度评价

本文评价

推荐阅读 0

[1]	尹义龙,袭肖明,孟宪静. 阿尔兹海默病的智能诊断方法[J]. 山东大学学报 (医学版), 2020, 1(8): 14-21.
[2]	余新光,张艳阳. 脑深部电刺激术在阿尔兹海默病中的应用进展[J]. 山东大学学报 (医学版), 2020, 1(8): 22-27,33.
[3]	苗玉连，武传龙，刘金波，张晓黎. 白藜芦醇对高脂饮食去卵巢肥胖大鼠脑组织炎症反应及海马Aβ1-42水平的影响[J]. 山东大学学报(医学版), 2013, 51(8): 17-21.
[4]	韩晓娟1，马学强2，杜怡峰1. 海风藤提取物对Aβ寡聚体激活的小胶质细胞释放炎性因子的抑制作用[J]. 山东大学学报(医学版), 2013, 51(5): 6-10.